SPONSORED RESEARCH AGREEMENT (NON-CLINICAL)


         This Agreement  ("Agreement")  is between Duke University  ("Duke"),  a
North Carolina  non-profit  corporation,  located in Durham,  North Carolina and
Cheung Laboratories,  Inc. ("Sponsor"), a Maryland corporation having offices at
10220-I Old Columbia Road, Columbia, Maryland 21046.

         WHEREAS,  the research  program  contemplated  by this  Agreement is of
mutual  interest  and  benefit  to  Duke  and  Sponsor,  and  will  further  the
instructional  and research  objectives of Duke in a manner  consistent with its
status as a non-profit educational institution.

         NOW, THEREFORE, the parties agree as follows:

                                    ARTICLE 1
                                STATEMENT OF WORK

         Duke  agrees to use its best  effort to perform  the  research  program
described in the "Statement of Work" ("Statement"),  a copy of which is attached
to this Agreement as Exhibit "A".

                                    ARTICLE 2
                             INDEPENDENT CONTRACTOR

         Duke's  relationship  to  Sponsor  under this  Agreement  will be of an
independent contractor and not an agent, joint venturer or partner of Sponsor.

                                    ARTICLE 3
                             PRINCIPAL INVESTIGATOR

         The research will be supervised by David Needham,  PhD ("Investigator")
at Duke.  If,  for any reason  Investigator  is unable to  continue  to serve as
Principal  Investigator  and a successor  acceptable to both Duke and Sponsor is
not  available,  the Agreement  will be terminated in accordance  with Article 7
below.

                                    ARTICLE 4
                                  CONSIDERATION

         In consideration of the foregoing, and as more specifically provided in
the  budget  included  as Exhibit  B,  Sponsor  will pay Duke for all direct and
indirect costs  incurred in the  performance of the research as set forth in the
Statement,  a total  not to  exceed  $184,336.  Payment  will be made to Duke by
Sponsor in advance, on the schedule set forth in Exhibit B.

483203.001(B&F)                        1                                01/11/99

<PAGE>

                                    ARTICLE 5
                              PERIOD OF PERFORMANCE

         The research  will be conducted  during a 1 year period  commencing  on
________, 19__ and concluding on or before ________________. This agreement will
be renewable for additional  periods upon the mutual consent of the parties by a
new  agreement or by  amendment  hereto  expressed in writing.  Either party may
terminate this  Agreement on any  anniversary  date of this Agreement  after the
first  anniversary date by giving the other party at least sixty (60) days prior
written notice of such termination.  In the case of such termination,  Duke will
proceed in an orderly  fashion to terminate any  outstanding  commitments and to
stop the work as soon as it is  practicable  to do so. All  reasonable  costs to
Duke  associated  with  termination  will  be  considered   reimbursable  costs,
including  costs incurred prior to the notice of termination  but which have not
yet  been  reimbursed,  and  commitments  existing  at the time  the  notice  of
termination is received which cannot be cancelled.

                                    ARTICLE 6
                                RESEARCH REPORTS

         Duke  will  provide  Sponsor  with  periodic  progress  reports  on the
research.  In addition,  Duke will  provide  Sponsor with a final report on such
research within sixty (60) days of termination of this Agreement.

                                    ARTICLE 7
                                   TERMINATION

         In the event that  either  party  commits a breach or default in any of
the terms or  conditions  of this  Agreement and that party fails to remedy that
default or breach  within  thirty (30) days after  receipt of written  notice of
that breach from the other party, the party giving notice may, at its option and
in  addition to any other  remedies  it may have in law or in equity;  terminate
this Agreement by sending written notice of termination to stop the work as soon
as it is practicable  to do so. All costs to Duke  associated  with  termination
will be considered  reimbursable  costs,  including  costs incurred prior to the
notice of termination  but which have not yet been  reimbursed,  and commitments
existing  at the time the notice of  termination  is  received  which  cannot be
cancelled.  This shall include all  noncancellable  contracts and fellowships or
postdoctoral  associate  appointments  incurred  prior to the effective  date of
termination.  After  termination,  any obligation of Sponsor for  fellowships or
postdoctoral  associates  shall end no later  than the first to occur of (i) the
end of Duke's academic year following termination.  or (ii) the next anniversary
date on which Sponsor could have terminated  this Agreement  pursuant to Article
5. In no case will reimbursement under this Agreement exceed the total estimated
project costs specified in Exhibit B.


483203.001(B&F)                        2                                01/11/99

<PAGE>

                                    ARTICLE 8
                            CONFIDENTIAL INFORMATION

         "Confidential  Information"  ("Information") shall mean all information
provided by one party to the other and clearly identified as confidential by the
transmitting  party at the time of disclosure.  Specifically  excepted from this
definition is all  information:  (a) known by the receiving party at the time of
disclosure;  (b)  publicly  disclosed  except by breach of this  Agreement;  (c)
rightfully received by the receiving party from a third party without an express
obligation of confidence;  and (d)  independently  developed by the employees or
agents of either party  without any  knowledge of the  confidential  information
provided by the other party. The party receiving the Information  agrees to hold
that Information in trust and confidence for the transmitting  party,  using the
same care and discretion that the receiving party uses with similar  Information
which it considers  confidential.  The receiving  party will not use Information
other than for the benefit of the two parties and relating to the  Agreement and
except as may be provided for in Article 9 regarding publication herein, neither
party will disclose such information without authorization from the other party.
This provision  shall remain in effect during the term of this Agreement and for
three (3) years thereafter.

                                    ARTICLE 9
                            PUBLICATION AND OTHER USE

         Duke shall be free to use the results of the subject  research  for its
own teaching, research,  educational,  clinical and publication purposes without
the payment of royalties or other fees. Duke agrees to submit to Sponsor for its
review, a copy of any proposed  publication  resulting from the subject research
at least sixty (60) days prior to the estimated date of  publication,  and if no
response is received  within thirty (30) days of the date  submitted to Sponsor,
it will be conclusively presumed that the publication may proceed without delay.
If Sponsor determines that the proposed  publication contains patentable subject
matters  which  require  protection,  Sponsor  may  require  the  delay  of  the
publication  for a period of time not to exceed  sixty (60) days for the purpose
of allowing the pursuit of such protection.

                                   ARTICLE 10
                                   INVENTIONS

         Any new invention, development, or discovery resulting from the subject
research  ("Invention")  shall be  promptly  disclosed  in writing  to  Sponsor.
Sponsor is hereby granted,  without option fee other than the  consideration  of
the  research  sponsored  herein  and the  reimbursement  of Duke for all patent
expenses incurred to the date of disclosure related to the Invention,  an option
to acquire an exclusive,  worldwide, royalty bearing license of Duke's rights to
any  Invention,  which option shall extend for ninety (90) days after  Sponsor's
receipt of an Invention  disclosure.  If Sponsor notifies Duke in writing of its
exercise of the option within the option  period,  then the parties will proceed


483203.001(B&F)                        3                                01/11/99

<PAGE>

in good faith to negotiate a license agreement on commercially  reasonable terms
within ninety (90) days after notification of exercise,  and if Sponsor does not
exercise this option, or notifies Duke that it will not exercise this option, or
the parties fail to sign a license agreement within said ninety (90) day period,
then Sponsor shall no longer own any rights in the subject Invention.

                                   ARTICLE 11
                             INDEMNITY AND INSURANCE

         Sponsor  agrees to  indemnify,  hold  harmless  and  defend  Duke,  its
officers,  employees,  and agents  against  any and all claims,  suits,  losses,
damages,  costs,  fees, and expenses asserted by third parties,  both government
and non-government,  resulting from or arising out of this agreement;  provided,
however,  that Sponsor shall not be responsible for Duke's negligence or willful
misconduct.  Sponsor shall maintain in force at its sole cost and expense,  with
reputable insurance  companies,  insurance of a type and in an amount reasonably
sufficient to protect against liability hereunder.  Duke shall have the right to
request the  appropriate  certificates of insurance from Sponsor for the purpose
of ascertaining the sufficiency of such coverage.

                                   ARTICLE 12
                              USE OF A PARTY'S NAME

         Neither  party  will,  without the prior  written  consent of the other
party: (a) use in advertising,  publicity or otherwise, the name of any employee
or agent, any trade-name,  trademark, trade device, service mark, symbol, or any
abbreviation, contraction or simulation thereof owned by the other party, or (b)
represent,  either  directly or  indirectly,  that any product or service of the
other party is a product or service of the representing party or that it is made
in accordance  with or utilizes the information or documents of the other party.
Notwithstanding  the  above,  Sponsor  shall have the right to state that it has
entered into this Agreement with Duke and to state or summarize the terms hereof
in  its  filings  with  the  Securities  and  Exchange  Commission  and  related
shareholder communications;  provided that Sponsor shall submit the text of such
statements to Duke at least 48 hours prior to publication.

                                   ARTICLE 13
                                     NOTICE

         Any notice or other  communication  required  or  permitted  under this
Agreement  will be in writing and will be deemed given as of the date it is: (a)
delivered by hand, or (b) mailed,  postage prepaid, first class, certified mail,
return  receipt  requested,  to  the  party  at  the  address  listed  below  or
subsequently specified in writing, or (c) sent, shipping prepaid, return receipt
requested, by national courier service, to the party at the address listed below
or subsequently specified in writing:


483203.001(B&F)                        4                                01/11/99

<PAGE>

         As to Duke:        Office of Grants and Contracts
                            107 Seeley G. Mudd Building
                            Duke University Medical Center - Box 3001
                            Durham, North Carolina 27710

                 cc:        University Counsel
                            Duke University - 011 Allen Building
                            Durham, North Carolina 27708

      As to Sponsor:        Cheung Laboratories, Inc.
                            10220-I Old Columbia Road
                            Columbia, Maryland 21046

               Attn:        Augustine Cheung

This Agreement is for professional research services.  Neither party may assign,
delegate  or  otherwise  transfer  any of its rights or  obligations  under this
Agreement without the prior written consent of the other party.

                                   ARTICLE 14
                                ENTIRE AGREEMENT

         This Agreement and all attached  Exhibits  contain the entire agreement
and  understanding  between the parties as to its subject matter.  It merges all
prior  discussions  between  the  parties  and  neither  party  will be bound by
conditions,   definitions,   warranties,   understandings,   or  representations
concerning  such  subject  matter  except as  provided in this  Agreement  or as
specified on or subsequent to the effective  date of this Agreement in a writing
signed by properly authorized representatives of the parties. This Agreement can
only be modified by written agreement duly signed by persons  authorized to sign
agreements on behalf of both Sponsor and Duke.

                                   ARTICLE 15
                                     WAIVER

         The  failure  of a party in any  instance  to  insist  upon the  strict
performance  of the terms of this Agreement will not be construed to be a waiver
or relinquishment  of any of the terms of this Agreement,  either at the time of
the  party's  failure to insist upon  strict  performance  or at any time in the
future, and such terms will continue in full force and effect.


483203.001(B&F)                        5                                01/11/99

<PAGE>

                                   ARTICLE 16
                                    SEVERANCE

         Each clause of this Agreement is a distinct and severable clause and if
any clause is deemed illegal, void or unenforceable,  the validity,  legality or
enforceability  of any other  clause or  portion of this  Agreement  will not be
affected thereby.

                                   ARTICLE 17
                                  GOVERNING LAW

         The  construction and performance of this Agreement will be governed by
the laws of the State of North Carolina.

                                   ARTICLE 18
                                     TITLES

         All  titles and  articles  headings  contained  in this  Agreement  are
inserted  only as a matter of  convenience  and  reference.  They do not define,
limit extend or describe the scope of this Agreement or the intent of any of its
provisions.


         IN WITNESS WHEREOF, the parties hereunto set their hands and seals.

                                                     DUKE UNIVERSITY



                                                     By: /s/ Ralph Hyderman
                                                     ----------------------
                                                       Name:
                                                       Title:

Date Executed:______________________

Principal Investigator:

                                                     SPONSOR:

                                                     CHEUNG LABORATORIES, INC.


                                                     By: /s/Augustine Y. Cheung
                                                     --------------------------
                                                       Name:
                                                       Title:Chairman


483203.001(B&F)                        6                                01/11/99

<PAGE>

Date Executed: March 17, 1998

                                Exhibit "B"

                             Payment Schedule

         ==================================  ===================
                  Payment Due Date                  Amount
         ----------------------------------  -------------------
                  January __, 1998                 $25,000
         ----------------------------------  -------------------
                  April __, 1998                   $53,112
         ----------------------------------  -------------------
                  July __, 1998                    $53,112
         ----------------------------------  -------------------
                  October __, 1998                 $53,112
         ----------------------------------  -------------------
                       Total                      $184,336
         ==================================  ===================


483203.001(B&F)                        7                                01/11/99

<PAGE>

                   SPONSORED RESEARCH AGREEMENT (NON-CLINICAL)


         This Agreement  ("Agreement")  is between Duke University  ("Duke"),  a
North Carolina  non-profit  corporation,  located in Durham,  North Carolina and
Cheung Laboratories,  Inc. ("Sponsor"), a Maryland corporation having offices at
10220-I Old Columbia Road, Columbia, Maryland 21046.

         WHEREAS,  the research  program  contemplated  by this  Agreement is of
mutual  interest  and  benefit  to  Duke  and  Sponsor,  and  will  further  the
instructional  and research  objectives of Duke in a manner  consistent with its
status as a non-profit educational institution.

         NOW, THEREFORE, the parties agree as follows:

                                    ARTICLE 4
                                STATEMENT OF WORK

         Duke  agrees to use its best  effort to perform  the  research  program
described in the "Statement of Work" ("Statement"),  a copy of which is attached
to this Agreement as Exhibit "A".

                                    ARTICLE 5
                             INDEPENDENT CONTRACTOR

         Duke's  relationship  to  Sponsor  under this  Agreement  will be of an
independent contractor and not an agent, joint venturer or partner of Sponsor.

                                    ARTICLE 6
                             PRINCIPAL INVESTIGATOR

         The  research  will  be  supervised  by  Mark  W.  Dewhirst,  DVM,  PhD
("Investigator")  at Duke. If, for any reason Investigator is unable to continue
to serve as Principal  Investigator and a successor  acceptable to both Duke and
Sponsor is not available,  the Agreement  will be terminated in accordance  with
Article 7 below.

                                    ARTICLE 4
                                  CONSIDERATION

         In consideration of the foregoing, and as more specifically provided in
the  budget  included  as Exhibit  B,  Sponsor  will pay Duke for all direct and

483203.001(B&F)                        8                                01/11/99

<PAGE>

indirect costs  incurred in the  performance of the research as set forth in the
Statement,  a total  not to  exceed  $440,726.  Payment  will be made to Duke by
Sponsor in advance, on the schedule set forth in Exhibit B.

                                    ARTICLE 5
                              PERIOD OF PERFORMANCE

         The research  will be conducted  during a 1 year period  commencing  on
February 1, 1998 and  concluding on or before  Janaury 31, 1999.  This agreement
will be renewable for additional  periods upon the mutual consent of the parties
by a new agreement or by amendment hereto expressed in writing. Either party may
terminate this  Agreement on any  anniversary  date of this Agreement  after the
first  anniversary date by giving the other party at least sixty (60) days prior
written notice of such termination.  In the case of such termination,  Duke will
proceed in an orderly  fashion to terminate any  outstanding  commitments and to
stop the work as soon as it is  practicable  to do so. All  reasonable  costs to
Duke  associated  with  termination  will  be  considered   reimbursable  costs,
including  costs incurred prior to the notice of termination  but which have not
yet  been  reimbursed,  and  commitments  existing  at the time  the  notice  of
termination is received which cannot be cancelled.

                                    ARTICLE 6
                                RESEARCH REPORTS

         Duke  will  provide  Sponsor  with  periodic  progress  reports  on the
research.  In addition,  Duke will  provide  Sponsor with a final report on such
research within sixty (60) days of termination of this Agreement.

                                    ARTICLE 7
                                   TERMINATION

         In the event that  either  party  commits a breach or default in any of
the terms or  conditions  of this  Agreement and that party fails to remedy that
default or breach  within  thirty (30) days after  receipt of written  notice of
that breach from the other party, the party giving notice may, at its option and
in  addition to any other  remedies  it may have in law or in equity;  terminate
this Agreement by sending written notice of termination to stop the work as soon
as it is practicable  to do so. All costs to Duke  associated  with  termination
will be considered  reimbursable  costs,  including  costs incurred prior to the
notice of termination  but which have not yet been  reimbursed,  and commitments
existing  at the time the notice of  termination  is  received  which  cannot be
cancelled.  This shall include all  noncancellable  contracts and fellowships or
postdoctoral  associate  appointments  incurred  prior to the effective  date of
termination.  After  termination,  any obligation of Sponsor for  fellowships or
postdoctoral  associates  shall end no later  than the first to occur of (i) the
end of Duke's academic year following termination.  or (ii) the next anniversary
date on which Sponsor could have terminated  this Agreement  pursuant to Article

483203.001(B&F)                        9                                01/11/99

<PAGE>

5. In no case will reimbursement under this Agreement exceed the total estimated
project costs specified in Exhibit B.

                                    ARTICLE 8
                            CONFIDENTIAL INFORMATION

         "Confidential  Information"  ("Information") shall mean all information
provided by one party to the other and clearly identified as confidential by the
transmitting  party at the time of disclosure.  Specifically  excepted from this
definition is all  information:  (a) known by the receiving party at the time of
disclosure;  (b)  publicly  disclosed  except by breach of this  Agreement;  (c)
rightfully received by the receiving party from a third party without an express
obligation of confidence;  and (d)  independently  developed by the employees or
agents of either party  without any  knowledge of the  confidential  information
provided by the other party. The party receiving the Information  agrees to hold
that Information in trust and confidence for the transmitting  party,  using the
same care and discretion that the receiving party uses with similar  Information
which it considers  confidential.  The receiving  party will not use Information
other than for the benefit of the two parties and relating to the  Agreement and
except as may be provided for in Article 9 regarding publication herein, neither
party will disclose such information without authorization from the other party.
This provision  shall remain in effect during the term of this Agreement and for
three (3) years thereafter.

                                    ARTICLE 9
                            PUBLICATION AND OTHER USE

         Duke shall be free to use the results of the subject  research  for its
own teaching, research,  educational,  clinical and publication purposes without
the payment of royalties or other fees. Duke agrees to submit to Sponsor for its
review, a copy of any proposed  publication  resulting from the subject research
at least sixty (60) days prior to the estimated date of  publication,  and if no
response is received  within thirty (30) days of the date  submitted to Sponsor,
it will be conclusively presumed that the publication may proceed without delay.
If Sponsor determines that the proposed  publication contains patentable subject
matters  which  require  protection,  Sponsor  may  require  the  delay  of  the
publication  for a period of time not to exceed  sixty (60) days for the purpose
of allowing the pursuit of such protection.

                                   ARTICLE 10
                                   INVENTIONS

         Any new invention, development, or discovery resulting from the subject
research  ("Invention")  shall be  promptly  disclosed  in writing  to  Sponsor.
Sponsor is hereby granted,  without option fee other than the  consideration  of
the  research  sponsored  herein  and the  reimbursement  of Duke for all patent
expenses incurred to the date of disclosure related to the Invention,  an option


483203.001(B&F)                       10                                01/11/99

<PAGE>

to acquire an exclusive,  worldwide, royalty bearing license of Duke's rights to
any  Invention,  which option shall extend for ninety (90) days after  Sponsor's
receipt of an Invention  disclosure.  If Sponsor notifies Duke in writing of its
exercise of the option within the option  period,  then the parties will proceed
in good faith to negotiate a license agreement on commercially  reasonable terms
within ninety (90) days after notification of exercise,  and if Sponsor does not
exercise this option, or notifies Duke that it will not exercise this option, or
the parties fail to sign a license agreement within said ninety (90) day period,
then Sponsor shall no longer own any rights in the subject Invention.

                                   ARTICLE 11
                             INDEMNITY AND INSURANCE

         Sponsor  agrees to  indemnify,  hold  harmless  and  defend  Duke,  its
officers,  employees,  and agents  against  any and all claims,  suits,  losses,
damages,  costs,  fees, and expenses asserted by third parties,  both government
and non-government,  resulting from or arising out of this agreement;  provided,
however,  that Sponsor shall not be responsible for Duke's negligence or willful
misconduct.  Sponsor shall maintain in force at its sole cost and expense,  with
reputable insurance  companies,  insurance of a type and in an amount reasonably
sufficient to protect against liability hereunder.  Duke shall have the right to
request the  appropriate  certificates of insurance from Sponsor for the purpose
of ascertaining the sufficiency of such coverage.

                                   ARTICLE 12
                              USE OF A PARTY'S NAME

         Neither  party  will,  without the prior  written  consent of the other
party: (a) use in advertising,  publicity or otherwise, the name of any employee
or agent, any trade-name,  trademark, trade device, service mark, symbol, or any
abbreviation, contraction or simulation thereof owned by the other party, or (b)
represent,  either  directly or  indirectly,  that any product or service of the
other party is a product or service of the representing party or that it is made
in accordance  with or utilizes the information or documents of the other party.
Notwithstanding  the  above,  Sponsor  shall have the right to state that it has
entered into this Agreement with Duke and to state or summarize the terms hereof
in  its  filings  with  the  Securities  and  Exchange  Commission  and  related
shareholder communications;  provided that Sponsor shall submit the text of such
statements to Duke at least 48 hours prior to publication.

                                   ARTICLE 13
                                     NOTICE

         Any notice or other  communication  required  or  permitted  under this
Agreement  will be in writing and will be deemed given as of the date it is: (a)
delivered by hand, or (b) mailed,  postage prepaid, first class, certified mail,
return  receipt  requested,  to  the  party  at  the  address  listed  below  or


483203.001(B&F)                       11                                01/11/99

<PAGE>

subsequently specified in writing, or (c) sent, shipping prepaid, return receipt
requested, by national courier service, to the party at the address listed below
or subsequently specified in writing:

         As to Duke:        Office of Grants and Contracts
                            107 Seeley G. Mudd Building
                            Duke University Medical Center - Box 3001
                            Durham, North Carolina 27710

                 cc:        University Counsel
                            Duke University - 011 Allen Building
                            Durham, North Carolina 27708

      As to Sponsor:        Cheung Laboratories, Inc.
                            10220-I Old Columbia Road
                            Columbia, Maryland 21046

               Attn:        Augustine Cheung

This Agreement is for professional research services.  Neither party may assign,
delegate  or  otherwise  transfer  any of its rights or  obligations  under this
Agreement without the prior written consent of the other party.

                                   ARTICLE 14
                                ENTIRE AGREEMENT

         This Agreement and all attached  Exhibits  contain the entire agreement
and  understanding  between the parties as to its subject matter.  It merges all
prior  discussions  between  the  parties  and  neither  party  will be bound by
conditions,   definitions,   warranties,   understandings,   or  representations
concerning  such  subject  matter  except as  provided in this  Agreement  or as
specified on or subsequent to the effective  date of this Agreement in a writing
signed by properly authorized representatives of the parties. This Agreement can
only be modified by written agreement duly signed by persons  authorized to sign
agreements on behalf of both Sponsor and Duke.

                                   ARTICLE 15
                                     WAIVER

         The  failure  of a party in any  instance  to  insist  upon the  strict
performance  of the terms of this Agreement will not be construed to be a waiver
or relinquishment  of any of the terms of this Agreement,  either at the time of
the  party's  failure to insist upon  strict  performance  or at any time in the
future, and such terms will continue in full force and effect.


483203.001(B&F)                       12                                01/11/99

<PAGE>

                                   ARTICLE 16
                                    SEVERANCE

         Each clause of this Agreement is a distinct and severable clause and if
any clause is deemed illegal, void or unenforceable,  the validity,  legality or
enforceability  of any other  clause or  portion of this  Agreement  will not be
affected thereby.

                                   ARTICLE 17
                                  GOVERNING LAW

         The  construction and performance of this Agreement will be governed by
the laws of the State of North Carolina.

                                   ARTICLE 18
                                     TITLES

         All  titles and  articles  headings  contained  in this  Agreement  are
inserted  only as a matter of  convenience  and  reference.  They do not define,
limit extend or describe the scope of this Agreement or the intent of any of its
provisions.


         IN WITNESS WHEREOF, the parties hereunto set their hands and seals.

                                                     DUKE UNIVERSITY



                                                     By: /s/Ralph Hyderman
                                                     ---------------------
                                                       Name:
                                                       Title:

Date Executed:______________________

Principal Investigator:

                                                     SPONSOR:

                                                     CHEUNG LABORATORIES, INC.


                                                     By: /s/Augustine Y. Cheung
                                                     --------------------------
                                                        Name:
                                                        Title: Chairman


483203.001(B&F)                       13                                01/11/99

<PAGE>

Date Executed: March 17, 1998

                              Exhibit "B"

                            Payment Schedule

         ==================================  ===================
                  Payment Due Date                  Amount
         ----------------------------------  -------------------
                  February __, 1998                $110,181
         ----------------------------------  -------------------
                  May __, 1998                     $110,181
         ----------------------------------  -------------------
                  August __, 1998                  $110,181
         ----------------------------------  -------------------
                  November __, 1998                $110,183
         ----------------------------------  -------------------
                       Total                       $440,726
         ==================================  ===================


483203.001(B&F)                       14                                01/11/99

Source: OneCLE Business Contracts.